Glasgow-based food technology startup ENOUGH — which pioneers sustainable protein production — has raised €40 million in growth funding co-led by climate tech VC World Fund and food tech investor CPT Capital, which continued its commitment.
ENOUGH was a spinout from the University of Strathclyde.
Other previous investors, including AXA IM Alts through the Axa Impact Fund, HAL Investments through 280ppm, Onassis Group through Olympic Investments Inc, Tailored Solutions and Scottish Enterprise, also followed on with new investment.
Founded in 2015 with a mission to serve the world’s growing demand for sustainable protein, ENOUGH produces ABUNDA mycoprotein, fermenting fungi using renewable feedstocks to produce alternative ingredient proteins at scale.
This ingredient will be used in alternative meat and dairy products sold in supermarkets and fast-food brands around the world through an array of partnerships, including M&S and Unilever.
ENOUGH recently opened a protein factory in Sas van Gent, Netherlands, to create ABUNDA at scale.
The new growth funding brings the total capital raised by ENOUGH to over €95 million.
This will enable the company to scale up capacity at its factory in the Netherlands to serve growing customer demand for ABUNDA mycoprotein whilst also growing its teams across its offices in Glasgow, London and at Sas van Gent.
The company aims to grow over one million tonnes of ABUNDA cumulatively by 2032, the equivalent of replacing five million cows or over one billion chickens, to feed a growing global population and tackle the unsustainable impact of traditional protein farming.
ENOUGH founder and CEO Jim Laird said: “ENOUGH has made great strides in the past few years to launch our new factory in the Netherlands and scale up to work with customers across the UK and Europe.
“With this new funding, we will accelerate that growth. The alternative protein market is a multi-billion dollar opportunity, and the ethical and environmental reasons to embrace non-animal protein sources are more pressing than ever.
“We’re delighted to be leading this food revolution with our proprietary ABUNDA mycoprotein. We’re excited to welcome our new investors World Fund and look forward to working closely with them on the next phase of growth for ENOUGH.”
World Fund founding partner Craig Douglas said: “We’re delighted to be supporting ENOUGH as they scale up to become the global leader in sustainable protein.
“The company is tackling crucial bottlenecks in the creation of sustainable protein, whilst using fewer resources and maintaining a zero-waste process, which is enabling ENOUGH to have a lower carbon footprint compared to other plant-based protein sources, whilst producing at scale and providing supply security to a growing market.
“It helps that the products featuring ABUNDA are delicious too.
“ENOUGH’s work has the potential to help combat food scarcity, reduce the use of resources in the food industry and reduce emissions on a global scale and we look forward to working with Jim and the team to help them achieve this.”
Harry Kalms of CPT Capital said: “We are excited to continue supporting the ENOUGH team to deliver high-quality, alternative protein solutions supporting change in the global food system.
“Since our first investment five years ago, ENOUGH has stood out as a company that is poised to make a meaningful positive impact on today’s unsustainable food system.
“Now, with the completion of their first industrial production facility and this growth financing round, ENOUGH is leveraging its strong foundations to move into a new phase of large-scale commercialisation.”